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Abstract
Purpose Central diabetes insipidus is characterised by
arginine vasopressin deﬁciency. Oxytocin is structurally
related to vasopressin and is synthesised in the same
hypothalamic nuclei, thus we hypothesised that patients
with acquired central diabetes insipidus and anterior hypo-
pituitarism would display an oxytocin deﬁciency. More-
over, psychological research has demonstrated that oxytocin
inﬂuences social and emotional behaviours, particularly
empathic behaviour. We therefore further hypothesised that
central diabetes insipidus patients would perform worse on
empathy-related tasks, compared to age-matched and
gender-matched clinical control (clinical control-isolated
anterior hypopituitarism) and healthy control groups.
Method Fifty-six participants (age 46.54± 16.30 yrs; cen-
tral diabetes insipidus: n= 20, 8 males; clinical control: n
= 15, 6 males; healthy control: n= 20, 7 males) provided
two saliva samples which were analysed for oxytocin and
completed two empathy tasks.
Results Hypopituitary patients (both central diabetes insi-
pidus and clinical control groups) had signiﬁcantly lower
oxytocin concentrations compared to healthy control parti-
cipants. Hypopituitary patients also performed signiﬁcantly
worse on both the reading the mind in the eyes task and the
facial expression recognition task compared to healthy
control participants. Regression analyses further revealed
that central diabetes insipidus patients’ oxytocin con-
centrations signiﬁcantly predicted their performance on
easy items of the reading the mind in the eyes task.
Conclusions Hypopituitarism may therefore be associated
with reduced oxytocin concentrations and impaired
empathic ability. While further studies are needed to repli-
cate these ﬁndings, our data suggest that oxytocin replace-
ment may offer a therapeutic approach to improve
psychological well-being in patients with hypopituitarism.
Keywords Central diabetes insipidus ● Hypopituitarism ●
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Introduction
Central diabetes insipidus (CDI) is an endocrine disorder
with an estimated prevalence of 1 in 25000 [1]. CDI is
characterised by a deﬁciency in arginine vasopressin
(AVP), which occurs due to a signiﬁcant loss (>80%) of
function in hypothalamic neurons responsible for AVP
synthesis [1]. AVP is the sister peptide of oxytocin (OT):
they differ in structure by just two amino acids [2] and are
produced in the paraventricular and supraoptic nuclei of the
hypothalamus, where they are transported to the posterior
pituitary gland for release into the peripheral circulation [3].
It seems likely therefore that patients with acquired CDI, as
a result of pituitary surgery, will also present with a deﬁ-
ciency in OT.
OT is known to initiate uterine contractions during par-
turition and to initiate the milk let-down reﬂex during
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lactation. There is currently no recognised endocrine phe-
notype associated with OT deﬁciency. However, psycho-
logical research has shown that OT plays an important role
in a range of social behaviours including increasing an
individual’s ability to identify emotional expressions [4, 5],
increasing the speed at which an individual accurately
identiﬁes emotional expressions [6], and regulating proso-
cial behaviour [7, 8]. As this line of research has developed,
so has the interest in the therapeutic potential of OT to treat
a range of psychological disorders that are characterised by
deﬁcits in these social behaviours. Indeed research has
shown that several of these disorders (autism spectrum
disorder [9], attention deﬁcit hyperactivity disorder [10],
and depression [11]) are associated with disrupted OT
systems, and that intranasal OT administration can
attenuate (to some extent) the characteristic empathy deﬁ-
cits [12, 13]. Thus prior research has shown that
speciﬁc psychological disorders show a deﬁcit in cognitive
empathy, and that cognitive empathy can be moderated
by OT.
The only study (to our knowledge) to investigate the
presence of an OT deﬁciency in a patient group found that
patients with childhood-onset craniopharyngiomas who had
grade 1 lesions to the hypothalamus as a result of surgical
resection had signiﬁcantly lower OT concentrations com-
pared to those with grade 2 lesions and those with no
hypothalamic involvement [14]. The same research group
went on to administer OT in ten of their patients [15],
ﬁnding that grade 1 lesion patients’ performance on an
empathy task improved after OT administration. The
authors concluded that that it was important to consider OT
with regard to potential behavioural pathologies in patients
with craniopharyngiomas, speciﬁcally that OT may have
beneﬁcial effects on cognitive empathy.
The present study is a logical extension of this research:
to investigate whether patients with acquired CDI would
present with lower salivary OT concentrations, compared to
a clinical and a healthy control (HC) group, and if so,




Fifty-ﬁve adults were recruited from the Endocrinology
clinic at the University Hospital Wales into one of three
groups: the CDI group, the clinical control (CC) group, and
the HC group. The diagnosis of CDI and anterior hypopi-
tuitarism (HP) was established as per routine clinical prac-
tice by the water deprivation test, and a combination of
basal and dynamic tests of anterior pituitary function,
respectively. Inclusion criteria included documented bio-
chemical evidence of anterior HP and CDI, if present.
Participants were also required to receive full hormone
replacement therapy for at least 3 months prior to study
entry, while those with a history of functioning pituitary
adenomas (acromegaly, prolactinoma or Cushing’s disease)
were included only if in biochemical remission. CC patients
were recruited using the same inclusion criteria, but were
excluded if there was a history of partial or transient CDI.
All participants in the CDI group had acquired CDI as a
result of transsphenoidal pituitary surgery. Participants were
excluded from the study if they were under 18 years of age,
pregnant or breastfeeding, or if they were unable to comply
fully with the protocol and study instructions. Participants
were also excluded if they presented with any concomitant
condition which could compromise the study objectives
and/or preclude the protocol-deﬁned procedures (e.g., psy-
chiatric disorders). Finally, both the CC and HC participants
were matched by age and gender to CDI patients; a one-way
analysis of variance (ANOVA) revealed that there was no
signiﬁcant difference in age between the three groups, and
there was a similar gender distribution between groups (see
Table 1 for details).
The study protocol was approved by Cardiff University
(study sponsor), the Research and Development Ofﬁce at
the Cardiff and Vale University Health Board and by the
Cambridge Central Research Ethics Committee (15/CMC/
6297). All participants provided written informed consent,
were fully debriefed at the end of the study, and ﬁnancially
compensated for their participation.
Materials
Reading the mind in the eyes (RMET) task
The RMET is a pre-existing validated measure of cognitive
empathy created by Baron-Cohen et al. [16]. Participants
are presented with 36 facial expressions displaying just the
eye region of the face, and are therefore only able to use the
eyes to infer the mental state of the actor (see Fig. 1). The
faces included male and female actors. For each face, there
are four response options and participants are asked to select
the word that they feel best describes the face. Participants
are instructed to work through the task at their own pace,
and could refer to a deﬁnition list of the words at any time.
A percentage of each participant’s total number of correct
responses was calculated, in addition to two subscale
scores, one for easy and one for difﬁcult items [4].
Facial emotion recognition (FER) task
A modiﬁed version of the FER task [12] was used to assess
participants’ accuracy in identifying facial expressions of
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emotion. Participants saw male and female faces from the
Ekman, Friesen [17] series, representing four ‘basic’ emo-
tions (happiness, anger, fear and sadness) and neutral faces.
Participants saw each expression six times at four different
intensities (25, 50, 75, and 100%; differing intensities were
created by morphing each expression with the actors’ neu-
tral face), seeing a total of 96 faces (see Fig. 2). For each
face, participants were asked “What emotion is this person
showing?” and asked to select the number corresponding to
that emotion (1= happy, 2= anger, 3= fear, 4= sad, 5=
neutral). Participants were instructed to work through the
task at their own pace. A percentage of each participant’s
correct responses was calculated. An error bias score was
also calculated for each expression by summing the number
of times participants incorrectly identiﬁed a face as
expressing a particular emotion (e.g., all the times a parti-
cipant reported fear, when the expression was another
emotion).
Personality measures
The Interpersonal Reactivity Index (IRI) [18] is a well-
established questionnaire, containing four subscales
(empathic concern, fantasy, personal distress and perspec-
tive taking). A mean for each subscale is calculated pro-
viding a measure of participants’ trait empathy. All
subscales obtained satisfactory internal consistency
(empathic concern: α= .682; fantasy: α= .722; personal
distress: α= .767; perspective taking: α= .814).
The Autism Quotient short version (AQ-S; [19]) is an
adapted 28-item version of the original 50-item
Autism Quotient [20], and provides a measure of partici-
pants’ tendencies to demonstrate autistic-like traits. Items
relate to ﬁve subscales: social skills, mind reading, restric-
ted and repetitive behaviour, imagination, and attention to
detail. A mean for each subscale is created. All subscales
apart from the restricted and repetitive behaviour subscale
obtained satisfactory internal consistency (social skills:
α= .752; mind reading: α= .702; restricted and repetitive
Fig. 1 Example stimulus from the reading the mind in the eyes test
Table 1 Clinical characteristics
of the CDI and CC patients
CDI (n) CC (n) HC (n) p-value
Age (years) 44.05± 3.6 51.69± 4.4 45.31± 3.8 .382
Gender 8 male 6 male 7 male
12 female 9 female 13 female
BMI (kg/m2) 32.72± 1.5 33.22± 1.7 27.66± 1.6 .031
Hypopituitarism Partial hypopituitarism 8 12 N/A
Panhypopituitarism 7 3
Eupituitary 5 0













Desmopressin 20 0 N/A
Hydrocortisone 11 10
Thyroxine 14 8
Growth hormone 2 2
Testosterone/oestrogen 8 3
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behaviour: α= .429; imagination: α= .629; attention to
detail: α= .706).
The Relationship Structure Questionnaire (ECR-RS) [21]
is a previously validated questionnaire containing nine
items about the participant’s relationship with their
mother and father. A mean is calculated for each parent,
providing a measure of participants’ attachment style.
Both scales obtained satisfactory internal consistency
(mother: α= .876; father: α= .890).
OT sampling and analysis
We chose to measure OT via saliva because (a) previous
research has demonstrated saliva is a valid medium for
measuring OT [14, 15, 22], (b) it is suggested that saliva has
lower rates of non-speciﬁc binding compared to plasma
samples [23], and (c) importantly, this is a non-invasive
method. Passive drool saliva samples were therefore col-
lected in pre-chilled tubes, stored on ice during the study,
and frozen in a −80 °C freezer immediately after the
second saliva sample was provided. Samples were then
centrifuged, lyophilised and analysed in accordance with
the manufacturer’s protocol, with an overnight incubation
time of 19 h [24]. Full details regarding sampling and
analysis are provided in [22]. Importantly, cross-reactivity
with AVP is <0.02% (based on values provided by the
manufacturer), thereby providing conﬁdence that despite
the structural similarity of vasopressin and OT, the results
obtained would not be artiﬁcially high in the CDI group as a
result of their desmopressin medication. The present study
obtained intra-assay and inter-assay coefﬁcients of <4% and
10.8–15.2%, respectively. All participants’ OT concentra-
tions are provided in the Supplementary Materials.
Procedure
Participants were instructed to abstain from alcohol for 24 h
and caffeine for an hour prior to testing. Participants were
only allowed to drink water during the study and if any food
had been consumed before the start of a session, participants
were asked to rinse their mouths thoroughly before any
saliva samples were taken. All testing was carried out
between 09:00 and 12:00 in order to control for any hor-
monal circadian rhythms.
On arrival, participants’ height and weight were mea-
sured in order that their body mass index (BMI) could be
calculated. After a brief period (approximately 10 min) of
acclimatisation to the testing facility, participants were
asked to provide their ﬁrst saliva sample before completing
either the RMET or FER task. Given the similarity of these
tasks, the order in which they were presented was coun-
terbalanced to control for any learning effects that might
arise from the ﬁrst task. Participants then completed the
personality measure questionnaires before providing their
second saliva sample, approximately 30 min later. After
this, participants completed a behavioural task that will not
be discussed here, before completing either the RMET or
FER task according to their counterbalance condition. Par-
ticipants were fully debriefed before leaving.
Data analysis
Saliva data
An analysis of covariance (ANCOVA) was conducted to
assess the effect of group on participants’ OT concentra-
tions, while controlling for age, medication and BMI. A
priori power calculations were based on our recent study in
Fig. 2 Example stimuli of the
FER
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which salivary OT concentrations were assessed in male
undergraduates [22], in whom we found a mean OT
concentration of 46 pg/ml with a standard deviation of
33 pg/ml. Accordingly, recruiting 20 participants in each
group would allow us to detect a 21 pg/ml standard devia-
tion with 80% power at the 5% alpha level.
Personality data
Three ANOVAs were carried out to assess whether there
were any group differences in each of the self-reported
personality measures (any main effects of subscale or
interactions were not the primary interest of the study and
therefore only reported in Supplementary Materials).
Empathy data
An ANCOVA was carried out to investigate any differences
in total RMET scores between groups, while controlling for
age and gender. To investigate the relationship between
RMET performance on easy and difﬁcult items and OT
concentrations, three multiple regression models were run in
order to investigate group differences.
A mixed ANCOVA was carried out to assess the inﬂu-
ence of different facial expressions, expression intensity,
and group on participants’ accuracy during the FER. This
analysis was repeated using participants’ OT concentrations
as a covariate to identify whether OT concentrations were
responsible for any observed group effects. Finally, a mixed
ANOVA was carried out to assess whether there was an
effect of any propensity of participants in a given group to
over-report emotions during the FER, subsequently termed
‘error bias’.
All reported analyses control for age and gender as
covariates, although age and gender were not signiﬁcant
covariates in any of these analyses.
Results
Descriptives
Table 1 summarises the medical characteristics of the CDI
and CC clinical groups. By design, the majority (75%) of
CDI patients had concomitant partial or pan-
hypopituitarism. Eighty percent of CC patients had partial
anterior HP, while the remainder were panhypopituitary.
The range of tumours removed during surgery is broadly
reﬂective of the diverse aetiology of both CDI and HP: 45%
of CDI patients had surgery for craniopharyngioma, a
common cause of CDI, compared to just one CC patient;
25% of CDI patients had a history of tumours producing
either growth hormone, prolactin, or both, compared to 40%
of CC patients; and 10% of CDI patients had non-
functioning pituitary adenomas, compared to 33% of CC
patients.
The age at which patients underwent surgery did not
differ signiﬁcantly between clinical groups, t(31)=−1.65,
p= .109, and ranged from 2 to 72 years of age; the mean
age at which patients underwent surgery was 36 years of
age.
Finally, a two-way ANOVA revealed a signiﬁcant dif-
ference in BMI between groups, F(2, 48)= 3.729, p= .031,
η2p = .134 (see Table 1 for details).
OT analysis
A 3 (Group: CDI vs. CC vs. HC; between-subjects)× 2
(samples: 1 vs. 2; within- subjects) mixed ANCOVA
revealed a trend towards a signiﬁcant main effect of
group on OT concentrations, F(2, 52)= 2.567, p= .086,
η2p = .090. A follow-up ANCOVA was carried out in which
the CDI and CC groups were combined into one HP group.
This analysis was deemed appropriate because (i) there was
a similarity between CDI and CC patients in OT con-
centrations; (ii) there was also a similarity between the CDI
and CC patients in empathy performance, as reported
below; (iii) the original analysis only achieved 49% power.
Normality analysis revealed an outlier in the HP group
which was removed, and also that the data did not meet the
assumption of normality. A log transformation was carried
out, after which the transformed values met the assumption
of normality. All statistical analyses reported below were
carried out on the transformed data. For ease of inter-
pretation, untransformed means and standard errors are
reported.
There was a signiﬁcant main effect of group, F(1, 46)=
4.922, p= .031, η2p = .097, HP patients having signiﬁcantly
lower OT concentrations compared to HC participants
(Fig. 3). Replicating the ﬁndings of the previous analysis,
there was no main effect of sample, F(1, 46)= .193,
Fig. 3 Average oxytocin concentrations for hypopituitary patients and
healthy control participants (±SE)
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p= .662, η2p = .004, no interaction, F(1, 46)= .082, p
= .776, η2p = .002.
Personality measures
A 4 (IRI subscale: empathic concern vs. fantasy vs. per-
spective taking vs. personal distress; within-subjects)× 3
(Group: CDI vs. CC vs. HC; between-subjects) mixed
ANOVA revealed that CC (M= 2.195, SE= .111) and CDI
(M= 2.220, SE= .102) patients had signiﬁcantly lower trait
empathy scores compared to HC (M= 2.538, SE= .096)
participants, F(2, 50)= 3.639, p= .033, η2p = .127.
A 4 (AQ-S Subscale: social skills vs. mind reading vs.
imagination vs. attention to detail; within-subjects)× 3
(Group: CDI vs. CC vs. HC; between-subjects) mixed
ANOVA revealed that CC patients (M= 2.502, SE= .095)
had signiﬁcantly lower AQ-S scores compared to HC (M=
2.952, SE= .085) participants, F(2, 51)= 6.269, p= .004,
η2p = .197. There was no difference between CDI patients
(M= 2.710, SE= .090) and HP patients or HC participants.
A 2 (ECR-RS Subscale: mother vs. father; within-sub-
jects)× 3 (Group: CDI vs. CC vs. HC; between-subjects)
mixed ANOVA revealed no main effects or interaction.
Empathy analysis
RMET
A one-way ANCOVA was carried out to investigate the
effect of group (CDI vs. CC vs. HC) on total RMET scores.
CDI and CC patients had signiﬁcantly lower RMET
scores compared to HC participants (Fig. 4), but there was
no difference between CDI and CC scores, F(2, 42)=
5.557, p= .007, η2p = .209.
Regression models conducted within each participant
group revealed that OT response predicted CDI participants’
performance on easy items (see Table 2).
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A mixed 4 (Emotion: happy vs. sad vs. fear vs. anger;
within-subjects)× 4 (intensity: 25 vs. 50 vs. 75 vs. 100;
within-subjects) × 3 (Group: CDI vs. CC vs. HC; between-
subjects) ANOVA revealed that CC patients (M= 61.122,
SE= 2.103) had signiﬁcantly lower scores than HC parti-
cipants (M= 70.590, SE= 1.870), but there was no dif-
ference between CDI patients (M= 65.949, SE= 1.840)
and CC or HC participants, F(2, 44)= 5.680, p= .006,
η2p = .205.
There was a signiﬁcant main effect of emotion and
intensity and a signiﬁcant interaction, full details of which
are provided in the Supplemental Materials.
Simple effects analyses were carried out to assess the
effect of group on recognition of expressions varying in
emotion and intensity. Group had no effect on recognition
of happy, sad, or angry expressions, but CC patients
(M= 55.833, SE= 2.986) correctly identiﬁed signiﬁcantly
fewer fearful expressions compared to HC participants
(M= 67.292, SE= 2.586), F(2, 51)= 4.331, p= .018, η2p
= .145; there was no difference between CDI and CC
patients. Unexpectedly, group also had a signiﬁcant effect
on high intensity facial expressions: 100%, F(2, 51)=
11.491, p< .001, η2p = .311; 75%, F(2, 51)= 6.308,
p= .004, η2p .198. At 100% intensity, both CC and CDI
patients identiﬁed fewer expressions correctly compared to
HC participants (there was no difference between CDI and
CC patients). At 75% intensity, CC patients correctly
identiﬁed fewer expressions compared to HC participants.
There was no effect of group on recognition of low intensity
expressions. The relevant means and standard errors are
presented in Fig. 5.
Finally, a 4 (emotion: happy vs. sad vs. fear vs. anger;
within-subjects) × 3 (Group: CDI vs. CC vs. HC; between-
subjects) mixed ANOVA revealed that CDI (M= 3.369,
SE= .392) and CC (M= 3.714, SE= .445) patients had
larger error biases compared to HC (M= 2.338, SE= .372)
participants, F(2, 49)= 3.962, p= .025, η2p = .139. Simple
effects analysis revealed a signiﬁcant difference between the
groups for fear bias, F(2, 49)= 4.002, p= .025, = .140,Fig. 4 RMET score as a function of clinical group (±SE)
Table 2 OT response speciﬁcally predicts CDI patients’ performance
for easy items, not difﬁcult items, of the RMET
Scale Group R2 F df p β
Easy CDI .277 6.513 (1,17) .021 .526
CC .214 2.730 (1,10) .129 .463
HC .022 .396 (1,18) .537 .147
Difﬁcult CDI .062 1.128 (1,17) .303 .249
CC .093 1.025 (1,10) .335 .305
HC .080 1.563 (1,18) .227 .283
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and anger bias, F(2, 49)= 5.559, p= .007, η2p = .185: CC
patients had a greater fear bias (M= 5.429, SE= .745)
compared to HC participants (M= 2.750, SE= .624), and
both CDI (M= 4.500, SE= .596) and CC (M= 5.000, SE
= .676) patients had a greater anger bias compared to HC
participants (M= 2.350, SE= .565).
OT was not a signiﬁcant covariate of participants’ FER
accuracy or of their error bias. The original main effects and
interaction remained signiﬁcant when controlling for OT.
Discussion
We investigated whether patients with acquired CDI,
characterised by a deﬁciency in AVP, would also demon-
strate a deﬁcit in OT, AVP’s ‘sister’ peptide, and if so,
whether they would also demonstrate a deﬁcit in cognitive
empathy (compared to a CC and HC participants). The
results are consistent with these hypotheses: HP patients had
signiﬁcantly lower OT concentrations compared to HC
participants, and also scored signiﬁcantly lower on the
RMET and FER compared to HC participants. However,
the prediction that CDI patients would have signiﬁcantly
lower OT concentrations than CC patients was not sup-
ported. This may reﬂect an inﬂuence of anterior pituitary
hormones on OT secretion or an unintentional disruption to
hypothalamic-pituitary neurones responsible for OT synth-
esis during surgery, an explanation that was supported in
previous research [14]. Because all CDI patients had
undergone transsphenoidal surgery the likelihood of hypo-
thalamic lesions accounting for these ﬁndings is low; it is
beyond the scope of the present study to quantify hypo-
thalamic involvement on the basis of scan data. CDI and CC
groups were subsequently collapsed into a new HP group
which was deemed justiﬁable because of the comparable
OT concentrations demonstrated in the original analysis; the
phenotypic similarity during the empathy tasks; and due to
the fact that the three group ANOVA was signiﬁcantly
underpowered.
Despite HP patients presenting with lower OT con-
centrations, their concentrations were not especially low. By
deﬁnition, patients with CDI had acquired sufﬁcient dis-
ruption to the hypothalamic–pituitary neurones to impair
AVP release; it could therefore be reasonably anticipated
that they would exhibit an equivalent and signiﬁcant
decrease in OT release. Although these results may poten-
tially be explained as a result of the similarity and potential
interaction between AVP and OT systems [25, 26], or as a
result of dendritic release of OT in other regions of the brain
[27], it should be acknowledged that HC concentrations
were also higher than expected. This may relate to issues of
noise in the ELISA method. While we accept this is a
limitation of the study, and are therefore cautious about
drawing conclusions on the basis of the absolute values
observed, there is no reason (to our knowledge) why noise
should vary signiﬁcantly between groups. Thus the sig-
niﬁcant difference between groups should not be dismissed.
HP patients also presented with a signiﬁcant empathy
deﬁcit. Initial analyses of self-report measures found that
HP patients had signiﬁcantly lower trait empathy compared
to HC participants. This was supported by experimental
data showing that CDI patients scored signiﬁcantly lower
on the RMET compared to HC participants, and partici-
pants’ OT concentrations signiﬁcantly predicted their per-
formance on the easy items of the RMET: the lower their
OT concentrations, the lower their score. On the FER task,
CC patients had signiﬁcantly lower overall scores than HC
participants, which was driven by a speciﬁc difﬁcultly in
identifying fearful facial expressions. The scores of CDI
patients tended to fall between the CC and HC scores. Both
CDI and CC patients were poorer at identifying high
intensity expressions (compared to HC participants), which
one would expect to be easier to identify. Both clinical
groups also demonstrated a greater error bias, compared to
HC participants; CC patients demonstrated a fear bias, in
that CC patients tended to over report fear when presented
with other emotions, and both CC and CDI patients had an
anger bias. However, participants’ OT concentrations were
not related to their FER performance.
These results support ﬁndings reported by Hoffmann
et al. [15] showing that grade 1 lesion craniopharyngioma
patients performed signiﬁcantly better on an empathy task
after OT administration, providing support for the beneﬁcial
role of OT in the emotional behaviour of medical patient
groups; and that this increase was driven by an improve-
ment at identifying negative emotions.
In the present study, a further novel ﬁnding was that CC
patients were signiﬁcantly worse at recognising fearful
facial expressions and while showing also a tendency to
report that other facial expressions depicted fear (when they
Fig. 5 FER performance as a function of intensity and clinical group
(±SE)
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did not) is especially noteworthy. Previous research has
demonstrated that clinical groups who over-report negative
(in particular fearful) expressions may be at greater risk of
developing mood disorders [28, 29]. The reverse may also
be true: patients with mood disorders display a bias towards
negative emotions [30]. Thus an important avenue for future
research is to investigate whether patients with HP are also
at an increased risk of mood disorders, especially in view of
the fact that previous research has shown that deﬁcits in
empathic ability have a signiﬁcant impact on social rela-
tionships [31, 32] and mood [33, 34]. Consistent with this
reasoning, a previous study [35] demonstrated that adults
who had childhood-onset multiple pituitary hormone deﬁ-
ciencies have a signiﬁcantly lower quality of life, compared
to their physically healthy peers. Moreover, the fact that CC
patients presented with low OT and a negative emotional
bias complements the approach/withdrawal hypothesis of
OT [36] suggesting that these patients may beneﬁt from OT
administration.
There are some limitations of the study that should be
acknowledged. We sought to recruit 20 participants for each
group; however, we were only able to recruit 15 CC patients
who were appropriately age- and gender-matched. Conse-
quently, the results pertaining to CC patients need to be
treated with some caution. A future study should therefore
aim to achieve a larger sample size to conﬁrm the gen-
eralisability of the present results. Such a study may also
wish to match participants on intellectual ability to control
for this variable. In addition, although we were speciﬁcally
interested in the effects of OT, we acknowledge that hor-
mones do not act in isolation and it may be the case that
other hormones/neurotransmitters could explain additional
variance between our groups. Importantly, a strength of the
study is the age range of participants (22–74). This, in
combination with the fact that age was not a signiﬁcant
covariate, suggests that age does not moderate any effects of
group or OT on cognitive empathy. Finally, it is important
to note that we did not administer intranasal OT, and thus
cannot draw inferences about causality.
In conclusion, the present study found that HP patients
had signiﬁcantly lower OT concentrations than HC parti-
cipants, and also had signiﬁcant deﬁcits in cognitive
empathy. Further studies are needed to replicate both these
and previous ﬁndings [15], in order to establish whether OT
supplementation can reverse these deﬁcits with a view to
improving psychological well-being.
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